The proteomics market is witnessing significant growth propelled by advancements in technology, such as mass spectrometry and protein microarrays, enabling researchers to delve deeper into the complexities of the proteome. Moreover, the escalating demand for targeted and precision medicine, coupled with the increasing prevalence of chronic diseases, further propels the adoption of proteomic solutions.
Allied Market Research published a report, titled, “Proteomics Market by Component (Reagents, Instruments, and Services), and Application (Drug Discovery, Disease Diagnosis, and Others): Global Opportunity Analysis and Industry Forecast, 2024-2035″. According to the report, the “proteomics market” was valued at $32.8 billion in 2023, and is estimated to reach $161.9 billion by 2035, growing at a CAGR of 14.2% from 2024 to 2035.
Proteomics focuses on the comprehensive analysis of proteins within a biological system. Unlike genomics, which examines the entirety of an organism’s genetic material, proteomics delves into the intricate world of proteins, the functional workhorses of cells. It involves the large-scale study of the structure, function, and interactions of proteins, aiming to understand their roles in biological processes and disease states. Proteomics employs various techniques, including mass spectrometry, protein microarrays, and bioinformatics tools, to identify, quantify, and characterize proteins present in cells, tissues, or organisms.
Request Sample of the Report on- https://www.alliedmarketresearch.com/request-sample/1677
Proteomics is the study of the complete set of proteins present in a biological system, offering valuable insights into cellular functions, interactions, and disease mechanisms. In the healthcare industry, proteomics has emerged as a powerful tool for biomarker discovery, drug development, and personalized medicine. By analyzing protein profiles in tissues, blood, or other bodily fluids, proteomics enables the identification of disease markers for early diagnosis and prognosis assessment. Additionally, it facilitates the development of targeted therapies by understanding the underlying molecular pathways involved in various diseases.
Key Takeaways
- On the basis of component, the reagent segment dominated the market in terms of revenue in 2023.
- On the basis of application, the drug discovery segment dominated the market in terms of revenue in 2023.
- On the basis of region, North America dominated the market in terms of revenue in 2023. However, Asia-Pacific is anticipated to grow at the highest CAGR during the forecast period.
2025 Recession Impact Analysis
- The global recession had a significant impact on the proteomics market.
- The economic uncertainty has negatively impacted the research and development activities in the proteomics market.
- However, the proteomics market is expected to recover owing to high adoption of proteomics for the treatment of chronic diseases and drug discovery and development procedures.
Segments Overview
By component:
The reagent segment held the highest market share in 2023 and is expected to dominate during the forecast period, accounting for more than three-fourths of the proteomics market revenue, owing to high use of reagents for every laboratory research work of proteomics. For instance, according to a 2024 article by the National Library of Medicine, it was reported that single cell proteomics analysis of drug response has shown its potential as a drug discovery platform.
The drug discovery segment to maintain its leadership status throughout the forecast period
By application:
The drug discovery segment held the highest market share in 2023, accounting for more than half of the proteomics market revenue. This is attributed to proteomics being widely adopted to evaluate the drug candidate in various parameters such as safety profile, efficacy, and toxicology during the preclinical trials.
By region:
North America held the highest market share in 2023, accounting for more than two-fifths of the proteomics market revenue. This is attributed to well-established healthcare infrastructure and rise in the prevalence of chronic diseases. However, Asia-Pacific is expected to register a noteworthy CAGR during the forecast period, owing to developing pharmaceutical industries in the region.
Leading Market Players:
- Bio-Rad Laboratories Inc
- Thermo Fisher Scientific Inc
- Danaher Corporation
- Bruker Corporation
- Waters Corporation
- Perkin Elmer Inc
- Horiba Ltd.
- Merck KGaA
- Agilent Technologies Inc
- Li-Cor Inc
You may Also Like
Image-Guided Radiation Therapy Market to Reach $3.3 Billion by 2033 | CAGR of 5.7%
Cannula Market Growth to Reach $316.9 million by 2033, Says Allied Market Research
Contact Details:
David Correa
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022
About Us
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
